Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy

BackgroundChemotherapy-induced cardiotoxicity is a concern for patients with gynecologic cancer. This study aimed to assess left ventricular (LV) myocardial deformation in patients with gynecologic cancer undergoing chemotherapy and to investigate the association between myocardial deformation and c...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai Tao, Lu Ye, Yan-Jia-Ni Xu, Meng-Xi Yang, Ru-Tie Yin, Qing-Li Li, Xiao-Juan Lin, Ke-Min Li, Liang Song, Yu Ma, Lan Zhong, Ying Hu, Hua-Yan Xu, Dan-Qing Wang, Ying-Kun Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1464368/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557398945955840
author Kai Tao
Kai Tao
Lu Ye
Yan-Jia-Ni Xu
Yan-Jia-Ni Xu
Meng-Xi Yang
Ru-Tie Yin
Qing-Li Li
Xiao-Juan Lin
Ke-Min Li
Liang Song
Yu Ma
Lan Zhong
Ying Hu
Hua-Yan Xu
Dan-Qing Wang
Ying-Kun Guo
author_facet Kai Tao
Kai Tao
Lu Ye
Yan-Jia-Ni Xu
Yan-Jia-Ni Xu
Meng-Xi Yang
Ru-Tie Yin
Qing-Li Li
Xiao-Juan Lin
Ke-Min Li
Liang Song
Yu Ma
Lan Zhong
Ying Hu
Hua-Yan Xu
Dan-Qing Wang
Ying-Kun Guo
author_sort Kai Tao
collection DOAJ
description BackgroundChemotherapy-induced cardiotoxicity is a concern for patients with gynecologic cancer. This study aimed to assess left ventricular (LV) myocardial deformation in patients with gynecologic cancer undergoing chemotherapy and to investigate the association between myocardial deformation and chemotherapy factors.MethodsCardiac magnetic resonance (CMR) was performed to assess LV deformation parameters using CMR tissue tracking based on cine images. Serum myocardial injury biomarker were measured. Deformation parameters were compared between healthy controls and patients. Changes in deformation were assessed as chemotherapy progressed. Correlations between LV deformation parameters, clinical characteristics, and serum myocardial injury biomarkers were also analyzed.ResultsA total of 86 patients with gynecologic cancer and 30 normal controls were included. Among the patients, 41 completed CMR follow-up with a median interval of 6 months. Compared to the controls, patients exhibited lower absolute value of global radial strain (GRS) (37.30 ± 8.94% vs. 44.32 ± 8.44%), global circumferential strain (GCS) (-22.12 ± 3.05% vs. -24.08 ± 2.13%) and global longitudinal strain (GLS) (median -15.72% [IQR-17.13 to -13.58%] vs. -17.51 ± 2.00 %) (all p < 0.05). Patients with preserved LV ejection fraction (LVEF) also showed impaired global strain (all p < 0.05). GRS (39.71 ± 8.09% vs. median 30.56% [IQR 26.52 to 38.15%]; p = 0.001), GCS (-23.45 ± 2.09% vs. median -19.71% [IQR -21.71 to -19.10%]; p < 0.001) and GLS (-16.17 ± 2.42% vs. median -12.12% [IQR -14.10 to -8.53%]; p< 0.001) further decreased as the number of chemotherapy cycles increased during follow-up (all p < 0.05). Multivariate analysis showed that GCS was independently associated with the number of chemotherapy regimens (Standard regression coefficient [β] = 0.397, p < 0.001).ConclusionsMyocardial deformation is more sensitive than LVEF in detecting subclinical left ventricular dysfunction in patients with gynecologic cancer undergoing chemotherapy. GCS was associated with the number of chemotherapy regimens.
format Article
id doaj-art-b817673d7e2f41a4b64b2bd02c751dc7
institution Kabale University
issn 2234-943X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-b817673d7e2f41a4b64b2bd02c751dc72025-02-03T05:12:02ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-02-011510.3389/fonc.2025.14643681464368Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapyKai Tao0Kai Tao1Lu Ye2Yan-Jia-Ni Xu3Yan-Jia-Ni Xu4Meng-Xi Yang5Ru-Tie Yin6Qing-Li Li7Xiao-Juan Lin8Ke-Min Li9Liang Song10Yu Ma11Lan Zhong12Ying Hu13Hua-Yan Xu14Dan-Qing Wang15Ying-Kun Guo16Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Ultrasound, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Cardiology, Laboratory of Cardiac Structure and Function at Institute of Cardiovascular Diseases, and Cardiac Structure and Function Research Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Gynaecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaBackgroundChemotherapy-induced cardiotoxicity is a concern for patients with gynecologic cancer. This study aimed to assess left ventricular (LV) myocardial deformation in patients with gynecologic cancer undergoing chemotherapy and to investigate the association between myocardial deformation and chemotherapy factors.MethodsCardiac magnetic resonance (CMR) was performed to assess LV deformation parameters using CMR tissue tracking based on cine images. Serum myocardial injury biomarker were measured. Deformation parameters were compared between healthy controls and patients. Changes in deformation were assessed as chemotherapy progressed. Correlations between LV deformation parameters, clinical characteristics, and serum myocardial injury biomarkers were also analyzed.ResultsA total of 86 patients with gynecologic cancer and 30 normal controls were included. Among the patients, 41 completed CMR follow-up with a median interval of 6 months. Compared to the controls, patients exhibited lower absolute value of global radial strain (GRS) (37.30 ± 8.94% vs. 44.32 ± 8.44%), global circumferential strain (GCS) (-22.12 ± 3.05% vs. -24.08 ± 2.13%) and global longitudinal strain (GLS) (median -15.72% [IQR-17.13 to -13.58%] vs. -17.51 ± 2.00 %) (all p < 0.05). Patients with preserved LV ejection fraction (LVEF) also showed impaired global strain (all p < 0.05). GRS (39.71 ± 8.09% vs. median 30.56% [IQR 26.52 to 38.15%]; p = 0.001), GCS (-23.45 ± 2.09% vs. median -19.71% [IQR -21.71 to -19.10%]; p < 0.001) and GLS (-16.17 ± 2.42% vs. median -12.12% [IQR -14.10 to -8.53%]; p< 0.001) further decreased as the number of chemotherapy cycles increased during follow-up (all p < 0.05). Multivariate analysis showed that GCS was independently associated with the number of chemotherapy regimens (Standard regression coefficient [β] = 0.397, p < 0.001).ConclusionsMyocardial deformation is more sensitive than LVEF in detecting subclinical left ventricular dysfunction in patients with gynecologic cancer undergoing chemotherapy. GCS was associated with the number of chemotherapy regimens.https://www.frontiersin.org/articles/10.3389/fonc.2025.1464368/fullcardiac magnetic resonancecardiotoxicitytissue trackingleft ventricular deformationneoplasm
spellingShingle Kai Tao
Kai Tao
Lu Ye
Yan-Jia-Ni Xu
Yan-Jia-Ni Xu
Meng-Xi Yang
Ru-Tie Yin
Qing-Li Li
Xiao-Juan Lin
Ke-Min Li
Liang Song
Yu Ma
Lan Zhong
Ying Hu
Hua-Yan Xu
Dan-Qing Wang
Ying-Kun Guo
Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
Frontiers in Oncology
cardiac magnetic resonance
cardiotoxicity
tissue tracking
left ventricular deformation
neoplasm
title Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
title_full Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
title_fullStr Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
title_full_unstemmed Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
title_short Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
title_sort assessment of myocardial deformation by cmr tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy
topic cardiac magnetic resonance
cardiotoxicity
tissue tracking
left ventricular deformation
neoplasm
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1464368/full
work_keys_str_mv AT kaitao assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT kaitao assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT luye assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT yanjianixu assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT yanjianixu assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT mengxiyang assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT rutieyin assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT qinglili assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT xiaojuanlin assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT keminli assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT liangsong assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT yuma assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT lanzhong assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT yinghu assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT huayanxu assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT danqingwang assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy
AT yingkunguo assessmentofmyocardialdeformationbycmrtissuetrackingrevealsleftventricularsubclinicalmyocardialdysfunctioninpatientswithgynecologiccancerundergoingchemotherapy